Evidence

BROWSE BY STUDY TYPE OR CONFERENCE
All
  • All
  • MODEL VALIDATION
  • CLINICAL VALIDATION
  • AACR
  • ASCO
  • ASH
BROWSE BY YEAR
All
  • All
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • Archive
Combination chemotherapy versus temozolomide (TMZ) for patients with MGMT methylated (m-MGMT) glioblastoma (GBM): Results of cellworks omics biosimulation—myCare-015

ASCO Meeting Library,

Prediction of Outcomes With a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated With Radiation Therapy and Temozolomide

International Journal of Radiation Oncology, Biology, Physics,

A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents

ASH Annual Meeting,

Role of mTOR Inhibitor Everolimus in the Treatment of Metastatic Thymic Epithelial Tumors

Journal of Thoracic Oncology,

A feedforward relationship between active Rac1 and phosphorylated Bcl-2 is critical for sustaining Bcl-2 phosphorylation and promoting cancer progression

Science Direct,

Computational Models Accurately Predict Multi-Cell Biomarker Profiles in Inflammation and Cancer

Nature, Scientific Reports,

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients

Blood Advances,

Computational biology model (CBM) predicts nutrient dependency of cancer patients based on Tumor Genomics: Implication of precision diet in cancer therapy

AACR,

STAY INFORMED

Top